Associate Director, Global Publications
Encoded Therapeutics
Summary
The Associate Director, Global Publications will play a key role within the Medical and Patient Affairs team, supporting the strategy, development, and execution of global scientific publication plans. This role is responsible for overseeing the translation of complex clinical, translational, and non-clinical data into high-impact manuscripts, abstracts, posters, and congress presentations. This position reports to the Director, Scientific Communications.
Job description
Responsibilities
- Strategic Publication Planning: Lead the development, alignment, and execution of comprehensive global publication plans across preclinical and clinical assets to support scientific communications goals.
- Publication Execution & Oversight: Drive the end-to-end development of peer-reviewed manuscripts, congress abstracts, posters, and oral presentations in collaboration with internal authors, external investigators, and medical writers.
- Cross-Functional Collaboration: Partner closely with Clinical Development/Sciences, Biometrics, Translational Research, Regulatory Affairs, and Medical Affairs to ensure scientific accuracy, data alignment, and timely publication of study findings.
- Steering Committee Leadership: Establish and manage program-specific Publication Steering Committees (PSCs) and author working groups; facilitate authorship meetings, consensus-building, and data disclosure reviews.
- Agency & Vendor Management: Manage, and oversee external medical communications agencies, scientific writers, and graphics vendors, within scope, and in alignment with company standards.
- Compliance & Governance: Ensure all publication deliverables strictly adhere to Encoded’s Publication Policies, Good Publication Practice guidelines, the International Committee for Medical Journal Editors Recommendations for the Conduct, and applicable regulatory standards.
- Systems & Workflow Management: Oversee publication management software/tools for submission tracking, Medical–Legal–Regulatory (MLR) reviews, author agreements, and archival processes.
- Congress Strategy & Execution: Contribute to strategic congress planning, coordinate publication disclosures aligned with key scientific congresses; oversee scientific session coverage, presentation logistics, and post-congress scientific debriefs.
- Support for Patient Advocacy and health economics and outcomes research (HEOR) publications, as needed
- Travel internationally & domestically as required.
Qualifications
- A minimum of twelve years of related experience with a Bachelor’s degree; or eight years and a Master’s degree; or a PhD with three to five years of experience; or equivalent experience.
- Three to five years of medical writing, publications, or scientific communications experience within the biotechnology/pharmaceutical industry or a medical communications agency. Strong understanding of scientific publication processes, data communication, medical terminology, statistical methods, and compliance principles.
- Proven ability to draft clear, concise scientific content and translate technical data for diverse audiences.
- Excellent writing, editing, and project management skills with strong attention to detail.
- Highly organized with the ability to manage multiple deliverables concurrently under standard supervision.
- Collaborative team player with strong interpersonal skills and comfort working across cross-functional teams.
- Ability to communicate complex scientific information empathetically with patient communities.
- Flexible, adaptable, and comfortable working in a dynamic, fast-paced environment.
- Proficiency in Word, Excel, PowerPoint, and Adobe presentation tools.
Preferred Qualifications
- Advanced degree (PhD, PharmD, or MD) in a life science field.
- Experience in gene therapy, epilepsy, neuroscience, or rare disease.
- Knowledge of digital and multimedia scientific communication formats.
- Comfort with graphic design and video editing tools
Requirements
- A minimum of twelve years of related experience with a Bachelor’s degree; or eight years and a Master’s degree; or a PhD with three to five years of experience; or equivalent experience.
- Three to five years of medical writing, publications, or scientific communications experience within the biotechnology/pharmaceutical industry or a medical communications agency.
- Strong understanding of scientific publication processes, data communication, medical terminology, statistical methods, and compliance principles.
- Proven ability to draft clear, concise scientific content and translate technical data for diverse audiences.
- Excellent writing, editing, and project management skills with strong attention to detail.
- Highly organized with the ability to manage multiple deliverables concurrently under standard supervision.
- Collaborative team player with strong interpersonal skills and comfort working across cross-functional teams.
- Ability to communicate complex scientific information empathetically with patient communities.
- Flexible, adaptable, and comfortable working in a dynamic, fast-paced environment.
- Proficiency in Word, Excel, PowerPoint, and Adobe presentation tools.
- Advanced degree (PhD, PharmD, or MD) in a life science field.
- Experience in gene therapy, epilepsy, neuroscience, or rare disease.
- Knowledge of digital and multimedia scientific communication formats.
- Comfort with graphic design and video editing tools
Benefits
- Competitive employer premium contributions
- Stock option grants
- Paid time off
- Sick time
- Holiday pay
- Parental leave program
- Pre-tax medical programs
- Dependent care programs
- Short-term disability
- Long-term disability
- Life insurance
- AD&D insurance
- Professional development opportunities
- Team-building events
- Fitness center
Company overview
Encoded Therapeutics is a clinical-stage biotechnology company pioneering precision genetic medicines for severe central nervous system (CNS) disorders. Founded in 2014 and headquartered in South San Francisco, California, the company is developing potentially disease-modifying gene therapies for pediatric CNS conditions using its proprietary vector engineering platform. Encoded's innovative approach combines novel regulatory elements and payloads with AAV vectors to achieve unprecedented gene specificity and cell selectivity, enabling targeted expression of therapeutic transgenes in specific cell types. The company's flagship program, ETX101, targets Dravet syndrome and has received RMAT designation from the FDA. Encoded's pipeline also includes programs for Angelman syndrome, Lennox-Gastaut syndrome, STXBP1-related disorders, Alzheimer's disease, and neuropathic pain. With a team of 51-200 employees and significant venture backing including a $135 million Series D round, Encoded is advancing potentially transformative one-time gene therapies that could address significant unmet medical needs in neurological disorders.